196 related articles for article (PubMed ID: 34481528)
1. High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center.
Huang L; Fu Q; Ye Y; Lin Y; Yan Q; Chen S
Arthritis Res Ther; 2021 Sep; 23(1):232. PubMed ID: 34481528
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study.
Li J; Wang S; Zheng J; Li Q; Li J; Lu L
Clin Rheumatol; 2023 Feb; 42(2):453-462. PubMed ID: 36301369
[TBL] [Abstract][Full Text] [Related]
3. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.
Chen X; Shu X; He L; Yang H; Lu X; Wang G; Ge Y
Rheumatology (Oxford); 2023 Oct; 62(10):3302-3309. PubMed ID: 36734589
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
Sabbagh SE; Neely J; Chow A; DeGuzman M; Lai J; Lvovich S; McGrath T; Pereira M; Pinal-Fernandez I; Roberts J; Rouster-Stevens K; Schmeling H; Sura A; Tarshish G; Tucker L; Rider LG; Kim S;
Rheumatology (Oxford); 2021 Feb; 60(2):829-836. PubMed ID: 32889531
[TBL] [Abstract][Full Text] [Related]
5. Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality.
Song S; Zhang Y; Yu J; Xie C; Chen Y; Zhang X
BMC Infect Dis; 2022 Dec; 22(1):961. PubMed ID: 36575406
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study.
Chan SCW; Chung HY; Lau CS; Li PH
Ann Clin Microbiol Antimicrob; 2021 Nov; 20(1):78. PubMed ID: 34763703
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
8. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
Atkinson A; Miro JM; Mocroft A; Reiss P; Kirk O; Morlat P; Ghosn J; Stephan C; Mussini C; Antoniadou A; Doerholt K; Girardi E; De Wit S; Kraus D; Zwahlen M; Furrer H;
J Int AIDS Soc; 2021 Jun; 24(6):e25726. PubMed ID: 34118121
[TBL] [Abstract][Full Text] [Related]
9. Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.
Liu L; Zhang Y; Liu S; Wang C; Zhang L; Guan W; Zhang X; Li W; Shu X; Li T
Rheumatology (Oxford); 2023 Sep; 62(9):3095-3100. PubMed ID: 36702462
[TBL] [Abstract][Full Text] [Related]
10. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study.
Tadros S; Teichtahl AJ; Ciciriello S; Wicks IP
Semin Arthritis Rheum; 2017 Jun; 46(6):804-809. PubMed ID: 27814896
[TBL] [Abstract][Full Text] [Related]
13. Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis.
Matraiah EH; Olisaka N; Philipos M; Walbaum D; Dospinescu P; Fluck N; Basu N; Kidder D
Clin Rheumatol; 2018 Jul; 37(7):1991-1996. PubMed ID: 29808456
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Rice ML; Barreto JN; Thompson CA; Mara KC; Tosh PK; Limper AH
Cancer Med; 2021 Aug; 10(15):5120-5130. PubMed ID: 34155819
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
Schmajuk G; Jafri K; Evans M; Shiboski S; Gianfrancesco M; Izadi Z; Patterson SL; Aggarwal I; Sarkar U; Dudley RA; Yazdany J
Semin Arthritis Rheum; 2019 Jun; 48(6):1087-1092. PubMed ID: 30449650
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
17. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.
Riedhammer C; Düll J; Kestler C; Kadel S; Franz J; Weis P; Eisele F; Zhou X; Steinhardt M; Scheller L; Mersi J; Waldschmidt JM; Einsele H; Turnwald D; Kortüm KM; Surat G; Rasche L
Ann Hematol; 2024 Apr; 103(4):1327-1332. PubMed ID: 38123879
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
Sarwar S; Carey B; Hegarty JE; McCormick PA
Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
Basiaga ML; Ross ME; Gerber JS; Ogdie A
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update.
Lee YT; Chuang ML
J Infect Dev Ctries; 2018 Oct; 12(10):824-834. PubMed ID: 32004150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
